Vision and Mission
Team and Partners
For whom we work
Version imprimable de cet article Printable version

Vision and Mission


Microorganisms are important for both the environment and human life. They play essential roles in many different processes, such as ecological equilibriums, bioremediation, food production, infectious diseases. Their importance is too often underestimated.


Interlifescience, by its specific expertise, is intended to perform promotion and consulting in all fields of microbiology, but particularly in medical microbiology and the biosecurity / biosafety domain. The objectives are to help public authorities and private companies to solve issues and problems related to microorganisms and hence, to improve life quality.

The activity of Interlifescience is international.

Our working charter

  1. Competence, quality, reliability, and speed are our driving forces
  2. The collaborators of Interlifescience are its main richness and the key of its success. They form a close team working together to maintain expertise and satisfaction at work
  3. When we lack competence in a particular field, we do not hesitate to collaborate with partners recognised for their expertise in that specific field
  4. Our ultimate goal is to serve the community, not to make extensive profits
The Association Round Table Antibiotics has been founded in Bern on June 24, 2019.
29 October 2019

The Round Table Antibiotics is a Swiss non-profit interdisciplinary Association gathering experts from medicine, research and economics of almost all Swiss universities, as well as committed personalities from industry or elsewhere.

The aim of the Association Round Table Antibiotics is to drive Switzerland’s contribution to innovation, research, and development of measures against antimicrobial resistance, particularly by promoting the market introduction of new active substances, which should be available to all countries worldwide.

Additional information:

Appeal to the Swiss Federal Council for an innovative financing model for the research on new antimicrobials
26 November 2017

On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.

The text of the call of November 9, 2017 can be seen under "Publications"

The World Antibiotic Awareness Week will be held on 13-19 November 2017. Switzerland will participate.
8 November 2017

With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).

Additional information: StAR NRP72

interlifescience   Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
ByteCode - informatique libre